ReviewExperimental and therapeutic medicine2018

Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs.

Nan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.